Physician profile
Robert P Robichaux
NPI 1053524686
$19,617.26
in general payments reported to CMS, 2019-2025
18 companies · $5,587 in 2025
The $5,587 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $327 · 2020: $441 · 2021: $684 · 2022: $1,888 · 2023: $4,623 · 2024: $6,066 · 2025: $5,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500 · Travel and Lodging: $4,906 · Food and Beverage: $3,870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
| Travel and Lodging | $4,906.20 |
| Food and Beverage | $3,870.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8,857.74 | 2021-2025 | Lifevest |
| Abbott Laboratories | $7,717.58 | 2019-2025 | Aveir, Ensite, Tacticath Ablation Catheter, Sensor Enabled |
| Boston Scientific Corporation | $2,181.20 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Resonate El Icd Vr, Rhythmia Mapping System |
| Irhythm Technologies, INC. | $204.67 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Pfizer INC. | $124.41 | 2019-2024 | |
| Biotronik INC. | $82.69 | 2019-2023 | Acticor 7 Vr-T Dx |
| Impulse Dynamics (USA) INC. | $82.11 | 2023 | Optimizer |
| Janssen Pharmaceuticals, INC | $58.67 | 2021-2024 | Xarelto |
| Medtronic, INC. | $58.67 | 2024-2025 | Linq II, Tyrx |
| Sanofi-Aventis U.S. LLC | $40.52 | 2024 | |
| Novartis Pharmaceuticals Corporation | $38.36 | 2023-2024 | |
| Biosense Webster, INC. | $34.19 | 2023 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $32.58 | 2020-2024 | Camzyos |
| Edwards Lifesciences Corporation | $28.57 | 2024 | Hemosphere |
| Kiniksa Pharmaceuticals International, Plc | $22.00 | 2024 | Arcalyst |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.96 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.05 | 2019 | |
| Medtronic Vascular, INC. | $16.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Robichaux listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.